Invasive cardiology supplies 2

Summary

The tender concerns the supply of invasive cardiology supplies, including products for congenital heart defects, occlusion devices and plugs, and large valvuloplasty catheters. The procurement is divided into 14 lots, and a tender may be submitted for one or more lots; partial tenders are not allowed within a lot. Up to two parallel tenders are permitted, allowing a maximum of three separate tenders in total. The estimated total value is approximately EUR 5 million excluding VAT over 48 months. The contract will initially run for four years and then continue indefinitely, with commencement planned for November or December 2026. Bidders must comply with the product and compliance requirements set out in the tender documents and Annex 1; offered products generally cannot be replaced after the procurement procedure has been completed.